MA26886A1 - Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens. - Google Patents

Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens.

Info

Publication number: MA26886A1
Authority: MA; Morocco
Prior art keywords: thyroidian; derivatives; useful; receptor ligands; malonamic acids
Prior art date: 2000-03-31

Application number

MA26837A

Other languages

English (en)

Inventor

Erik Aspnes Gary

Gail Estep Kimberly

Phoebe Chiang Yuan-Ching

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-31

Filing date

2002-09-24

Publication date

2004-12-20

2002-09-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26886A1 publication Critical patent/MA26886A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/80—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MA26837A 2000-03-31 2002-09-24 Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens. MA26886A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US19361800P	2000-03-31	2000-03-31

Publications (1)

Publication Number	Publication Date
MA26886A1 true MA26886A1 (fr)	2004-12-20

Family

ID=22714346

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26837A MA26886A1 (fr)	2000-03-31	2002-09-24	Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens.

Country Status (38)

Country	Link
US (1)	US20070173548A1 (fr)
EP (1)	EP1268404B1 (fr)
JP (1)	JP3866977B2 (fr)
KR (1)	KR20020089420A (fr)
CN (1)	CN1422246A (fr)
AP (1)	AP2002002634A0 (fr)
AR (1)	AR033516A1 (fr)
AT (1)	ATE382602T1 (fr)
AU (1)	AU2001237665A1 (fr)
BG (1)	BG107036A (fr)
BR (1)	BR0109625A (fr)
CA (1)	CA2403902C (fr)
CR (1)	CR6742A (fr)
CZ (1)	CZ20023190A3 (fr)
DE (1)	DE60132181D1 (fr)
DZ (1)	DZ3276A1 (fr)
EA (1)	EA200200921A1 (fr)
EE (1)	EE200200566A (fr)
GT (1)	GT200100041A (fr)
HK (1)	HK1052498A1 (fr)
HU (1)	HUP0300329A3 (fr)
IL (1)	IL151376A0 (fr)
IS (1)	IS6516A (fr)
MA (1)	MA26886A1 (fr)
MX (1)	MXPA02009702A (fr)
NO (1)	NO20024639D0 (fr)
NZ (1)	NZ520660A (fr)
OA (1)	OA12237A (fr)
PA (1)	PA8513801A1 (fr)
PE (1)	PE20011186A1 (fr)
PL (1)	PL358596A1 (fr)
SK (1)	SK13762002A3 (fr)
SV (1)	SV2002000357A (fr)
TN (1)	TNSN01048A1 (fr)
TR (1)	TR200202249T2 (fr)
WO (1)	WO2001072692A1 (fr)
YU (1)	YU74102A (fr)
ZA (1)	ZA200207444B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6599942B1 (en)	1999-03-29	2003-07-29	Novartis Ag	Thyromimetic organic compounds
US6790978B2 (en)	1999-03-29	2004-09-14	Novartis Ag	Thyromimetic organic compounds
DK1257526T3 (da) *	2000-02-17	2005-09-12	Bristol Myers Squibb Co	Anilin-afledte ligander til thyreoidea-receptoren
EP1347959A1 (fr) *	2000-12-27	2003-10-01	Bayer Aktiengesellschaft	Derives de l'indole utilises comme ligands de recepteurs de la thyroide
GB2374009A (en) *	2001-02-12	2002-10-09	Novartis Ag	Method of treating hair loss
KR20040027927A (ko)	2001-08-24	2004-04-01	카로 바이오 아베	심장 및 대사 장애의 치료를 위해 주요 환이 치환된갑상선 수용체 길항근
US6806381B2 (en)	2001-11-02	2004-10-19	Bristol-Myers Squibb Company	Process for the preparation of aniline-derived thyroid receptor ligands
TW200504021A (en)	2003-01-24	2005-02-01	Bristol Myers Squibb Co	Substituted anilide ligands for the thyroid receptor
CN1882327A (zh)	2003-11-19	2006-12-20	症变治疗公司	含磷的新的拟甲状腺素药
US20090232879A1 (en)	2005-05-26	2009-09-17	Metabasis Therapeutics, Inc.	Thyromimetics for the Treatment of Fatty Liver Diseases
GB0606201D0 (en) *	2006-03-28	2006-05-10	Karobio Ab	Improved crytalline material
JP2010500300A (ja)	2006-08-08	2010-01-07	サノフィ−アベンティス	アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
US8633245B2 (en) *	2008-04-11	2014-01-21	Institute Of Medicinal Molecular Design, Inc.	PAI-1 inhibitor
AU2009234899A1 (en) *	2008-04-11	2009-10-15	Institute Of Medicinal Molecular Design, Inc.	PAI-1 inhibitor
US8470841B2 (en)	2008-07-09	2013-06-25	Sanofi	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
EP2346814A2 (fr)	2008-10-27	2011-07-27	Cadila Healthcare Limited	Ligands du recepteur de thyroide
WO2010068601A1 (fr)	2008-12-08	2010-06-17	Sanofi-Aventis	Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
WO2010086878A2 (fr)	2009-01-09	2010-08-05	Cadila Healthcare Limited	Modulateurs des récepteurs de la thyroïde
MX2012001729A (es)	2009-08-26	2012-06-13	Sanofi Sa	Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120057A1 (fr)	2011-03-08	2012-09-13	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
EP2683700B1 (fr)	2011-03-08	2015-02-18	Sanofi	Dérivés d'oxathiazine tétra-substitués, leur procédé de fabrication, leur utilisation comme médicament ainsi que médicaments en étant pourvu et leur utilisation
EP2683701B1 (fr)	2011-03-08	2014-12-24	Sanofi	Dérivés d'oxathiazine substitués par des groupes de benzyle-méthyles ou d'hétéro-méthyles, leur procédé de fabrication, leur utilisation comme médicament ainsi que médicaments en étant pourvu et leur utilisation
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120050A1 (fr)	2011-03-08	2012-09-13	Sanofi	Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation
WO2012120052A1 (fr)	2011-03-08	2012-09-13	Sanofi	Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
EP2683699B1 (fr)	2011-03-08	2015-06-24	Sanofi	Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
EP2567959B1 (fr)	2011-09-12	2014-04-16	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2695611B1 (fr)	2012-08-06	2014-10-01	Dr. August Wolff GmbH & Co. KG Arzneimittel	Eprotirome pour l'utilisation dans la prévention et/ou le traitement de troubles de cheveux et compositions correspondantes
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
WO2015156302A1 (fr) *	2014-04-09	2015-10-15	ゴールドクレスト医薬研究所株式会社	Agent permettant d'atténuer les symptômes cutanés, agent pour la croissance des cheveux ou agent amincissant
US11202789B2 (en)	2016-11-21	2021-12-21	Viking Therapeutics, Inc.	Method of treating glycogen storage disease
CN110996966A (zh)	2017-06-05	2020-04-10	维京治疗公司	用于治疗纤维化的组合物
CN107474007B (zh) *	2017-08-28	2019-04-19	上海再启生物技术有限公司	一种制备3，6-二羟基苯二甲酰亚胺的方法
JP2021518403A (ja)	2018-03-22	2021-08-02	バイキング・セラピューティクス・インコーポレイテッド	化合物の結晶形態及び化合物の結晶形態を生成する方法
JP2022510691A (ja)	2018-12-05	2022-01-27	バイキング・セラピューティクス・インコーポレイテッド	線維症及び炎症の処置のための組成物
TW202115029A (zh) *	2019-07-31	2021-04-16	大陸商深圳微芯生物科技股份有限公司	雜環化合物及其用途
EP3878837A1 (fr) *	2020-03-11	2021-09-15	OM Pharma SA	Dérivés d'hydroquinone 2,5- ou 2,6-disubstitutuées avec au moins un groupe carboxy, sulfo ou amido utiles comme médicaments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4069343A (en) *	1973-03-23	1978-01-17	American Home Products Corporation	Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
US4554290A (en) *	1983-06-17	1985-11-19	Ciba-Geigy Corporation	Oxamic acid derivatives
GB8501372D0 (en) *	1985-01-18	1985-02-20	Smith Kline French Lab	Chemical compounds
US5061798A (en) *	1985-01-18	1991-10-29	Smith Kline & French Laboratories, Ltd.	Benzyl pyridyl and pyridazinyl compounds
US5232947A (en) *	1988-07-04	1993-08-03	Meiji Seika Kaisha, Ltd.	Oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain
US5284971A (en) *	1992-07-16	1994-02-08	Syntex (U.S.A.) Inc.	4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
ATE159515T1 (de) *	1992-07-21	1997-11-15	Ciba Geigy Ag	Oxamidsäure-derivate als hypocholesterämische mittel
CO5160290A1 (es) *	1999-03-29	2002-05-30	Novartis Ag	Derivados de acido fenoxifeniloxamico sustituido .
AU3507700A (en) *	1999-06-01	2000-12-18	University Of Texas Southwestern Medical Center, The	Method of treating hair loss using diphenylether derivatives
US6664291B2 (en) *	2000-03-31	2003-12-16	Pfizer, Inc.	Malonamic acids and derivatives thereof as thyroid receptor ligands

2001
- 2001-03-07 HU HU0300329A patent/HUP0300329A3/hu unknown
- 2001-03-07 AP APAP/P/2002/002634A patent/AP2002002634A0/en unknown
- 2001-03-07 MX MXPA02009702A patent/MXPA02009702A/es active IP Right Grant
- 2001-03-07 CN CN01807559A patent/CN1422246A/zh active Pending
- 2001-03-07 IL IL15137601A patent/IL151376A0/xx unknown
- 2001-03-07 PL PL01358596A patent/PL358596A1/xx not_active Application Discontinuation
- 2001-03-07 EA EA200200921A patent/EA200200921A1/ru unknown
- 2001-03-07 EP EP01910082A patent/EP1268404B1/fr not_active Expired - Lifetime
- 2001-03-07 NZ NZ520660A patent/NZ520660A/en not_active Application Discontinuation
- 2001-03-07 SK SK1376-2002A patent/SK13762002A3/sk not_active Application Discontinuation
- 2001-03-07 WO PCT/IB2001/000317 patent/WO2001072692A1/fr active IP Right Grant
- 2001-03-07 JP JP2001570607A patent/JP3866977B2/ja not_active Expired - Fee Related
- 2001-03-07 TR TR2002/02249T patent/TR200202249T2/xx unknown
- 2001-03-07 EE EEP200200566A patent/EE200200566A/xx unknown
- 2001-03-07 AU AU2001237665A patent/AU2001237665A1/en not_active Abandoned
- 2001-03-07 CZ CZ20023190A patent/CZ20023190A3/cs unknown
- 2001-03-07 OA OA1200200299A patent/OA12237A/en unknown
- 2001-03-07 KR KR1020027013044A patent/KR20020089420A/ko not_active Application Discontinuation
- 2001-03-07 DZ DZ013276A patent/DZ3276A1/fr active
- 2001-03-07 YU YU74102A patent/YU74102A/sh unknown
- 2001-03-07 CA CA002403902A patent/CA2403902C/fr not_active Expired - Fee Related
- 2001-03-07 AT AT01910082T patent/ATE382602T1/de not_active IP Right Cessation
- 2001-03-07 BR BR0109625-7A patent/BR0109625A/pt not_active IP Right Cessation
- 2001-03-07 DE DE60132181T patent/DE60132181D1/de not_active Expired - Lifetime
- 2001-03-16 PA PA20018513801A patent/PA8513801A1/es unknown
- 2001-03-19 GT GT200100041A patent/GT200100041A/es unknown
- 2001-03-28 PE PE2001000290A patent/PE20011186A1/es not_active Application Discontinuation
- 2001-03-29 AR ARP010101509A patent/AR033516A1/es unknown
- 2001-03-30 SV SV2001000357A patent/SV2002000357A/es not_active Application Discontinuation
- 2001-03-30 TN TNTNSN01048A patent/TNSN01048A1/fr unknown
2002
- 2002-08-21 IS IS6516A patent/IS6516A/is unknown
- 2002-08-26 BG BG107036A patent/BG107036A/bg unknown
- 2002-08-28 CR CR6742A patent/CR6742A/es not_active Application Discontinuation
- 2002-09-17 ZA ZA200207444A patent/ZA200207444B/en unknown
- 2002-09-24 MA MA26837A patent/MA26886A1/fr unknown
- 2002-09-27 NO NO20024639A patent/NO20024639D0/no not_active Application Discontinuation
2003
- 2003-07-08 HK HK03104860.6A patent/HK1052498A1/zh unknown
2007
- 2007-03-07 US US11/715,035 patent/US20070173548A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1052498A1 (zh)	2003-09-19
YU74102A (sh)	2006-03-03
OA12237A (en)	2003-10-23
KR20020089420A (ko)	2002-11-29
MXPA02009702A (es)	2003-03-27
ATE382602T1 (de)	2008-01-15
NZ520660A (en)	2004-03-26
CA2403902A1 (fr)	2001-10-04
DE60132181D1 (de)	2008-02-14
AR033516A1 (es)	2003-12-26
TR200202249T2 (tr)	2003-01-21
CZ20023190A3 (cs)	2003-10-15
PA8513801A1 (es)	2002-02-21
AP2002002634A0 (en)	2002-09-30
HUP0300329A2 (hu)	2003-07-28
EP1268404A1 (fr)	2003-01-02
CR6742A (es)	2003-11-25
TNSN01048A1 (fr)	2005-11-10
AU2001237665A1 (en)	2001-10-08
IL151376A0 (en)	2003-04-10
HUP0300329A3 (en)	2004-08-30
EP1268404B1 (fr)	2008-01-02
NO20024639L (no)	2002-09-27
CN1422246A (zh)	2003-06-04
US20070173548A1 (en)	2007-07-26
BG107036A (bg)	2003-04-30
DZ3276A1 (fr)	2001-10-04
WO2001072692A1 (fr)	2001-10-04
PL358596A1 (en)	2004-08-09
BR0109625A (pt)	2003-04-22
JP2003528847A (ja)	2003-09-30
PE20011186A1 (es)	2001-11-15
CA2403902C (fr)	2007-04-24
NO20024639D0 (no)	2002-09-27
IS6516A (is)	2002-08-21
EE200200566A (et)	2004-06-15
EA200200921A1 (ru)	2003-02-27
SK13762002A3 (sk)	2004-01-08
GT200100041A (es)	2002-03-22
SV2002000357A (es)	2002-07-16
ZA200207444B (en)	2003-09-17
JP3866977B2 (ja)	2007-01-10

Publication	Publication Date	Title
MA26886A1 (fr)	2004-12-20	Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens.
MA26385A1 (fr)	2004-11-01	Derives de 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate
TR200000520A3 (tr)	2001-06-21	4-Fenil-piridin türevleri.
DZ3439A1 (fr)	2001-12-13	Derives de 2-aminocarbonyl-9h-purine
IS2556B (is)	2009-10-15	Nýjar kínasólín afleiður.
DE60019577D1 (de)	2005-05-25	4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
BR0005401B1 (pt)	2008-11-18	artigo absorvente.
MA26794A1 (fr)	2004-12-20	Derives de 5-phenyl-pyrimidine.
BR0013417B1 (pt)	2013-07-16	composiÇço aquosa.
BR0208970B1 (pt)	2011-05-31	produto absorvente com ajuste melhorado.
BR0208971B1 (pt)	2011-04-19	produto absorvente com ajuste melhorado.
BR0208969B1 (pt)	2011-04-19	produto absorvente com ajuste melhorado.
FR2810318B1 (fr)	2005-09-23	Derives de diamano-phenothiazine
DZ3036A1 (fr)	2004-03-27	Dérivés de monofluoroalkyles.
MA26793A1 (fr)	2004-12-20	Derives de 4-phenyl-pyrimidine.
DE60029755D1 (de)	2006-09-14	Congawandschutz.
DE60129123D1 (de)	2007-08-09	BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
IT1319526B1 (it)	2003-10-20	Macchina i.s.
IT1319528B1 (it)	2003-10-20	Macchina i.s.
ES1043131Y (es)	2000-05-01	Tejido perfeccionado.
ES1041748Y (es)	1999-12-16	Pantalon perfeccionado.
ES1050596Y (es)	2002-08-16	Disposicion de soporte extraible perfeccionada.
FR2790466B1 (fr)	2011-02-25	Machine i.s.
ITSS990004V0 (it)	1999-06-08	Piramide - ricordo.
IT1313517B1 (it)	2002-07-24	Gruppo - ventilatore per atomizzatori usati in agricoltura.